It is a horrible PR and shows you that this company still is wet behind the ears. If this wasn't a fledgling Biotech, someone would get fired over this. Gerald has done his shareholders a disservice by not getting this information out sooner instead of just dumping it the day before the conference. Very unprofessional, imho and I hope he didn't mislead pending partners, KOL as he has his shareholders.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.